Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11239-020-02270-w http://scihub22266oqcxt.onion/10.1007/s11239-020-02270-w 32889620!7474490!32889620     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32889620&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Thromb+Thrombolysis 2021 ; 51 (4): 941-946 Nephropedia Template TP {{tp|p=32889620|t=2021. Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19 |pdf=|usr=}}{{32889620}} gab.com Text Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19 JO: J Thromb Thrombolysis http://www.kidney.de/pget.php?&tw=1&pmid=32889620 #FOAvip Coagulation dysfunction and inflammatory status were compared between diabetic and non-diabetic COVID-19 patients. The standardized mean difference (SMD) and its 95% confidence interval (CI) was computed for the difference of inflammatory and hypercoagulability markers. The levels of serum ferritin (standardized mean difference-SMD: 0.47, CI 0.17-0.77, p = 0.002), C-reactive protein (SMD = 0.53, CI 0.20-0.86, p = 0.002), interleukin-6 (SMD = 0.31, CI 0.09-0.52, p = 0.005), fibrinogen (SMD = 0.31, CI 0.09-0.54, p = 0.007) and D-dimers (SMD = 0.54, CI 0.16-0.91, p = 0.005) were significantly higher in diabetic COVID-19 cases as compared to non-diabetic COVID-19 patients, suggesting more susceptibility of diabetic COVID-19 patients to coagulation dysfunction and inflammatory storm. Twit Text FOAVip Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19 ????J Thromb Thrombolysis http://www.kidney.de/pget.php?&tw=1&pmid=32889620 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32889620 #FOAvip English Wikipedia <ref>{{Cite pmid|32889620}}</ref> Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19 #MMPMID32889620 Varikasuvu SR; Varshney S; Dutt N J Thromb Thrombolysis 2021[May]; 51 (4): 941-946 PMID32889620show ga Coagulation dysfunction and inflammatory status were compared between diabetic and non-diabetic COVID-19 patients. The standardized mean difference (SMD) and its 95% confidence interval (CI) was computed for the difference of inflammatory and hypercoagulability markers. The levels of serum ferritin (standardized mean difference-SMD: 0.47, CI 0.17-0.77, p = 0.002), C-reactive protein (SMD = 0.53, CI 0.20-0.86, p = 0.002), interleukin-6 (SMD = 0.31, CI 0.09-0.52, p = 0.005), fibrinogen (SMD = 0.31, CI 0.09-0.54, p = 0.007) and D-dimers (SMD = 0.54, CI 0.16-0.91, p = 0.005) were significantly higher in diabetic COVID-19 cases as compared to non-diabetic COVID-19 patients, suggesting more susceptibility of diabetic COVID-19 patients to coagulation dysfunction and inflammatory storm. |*COVID-19/blood/epidemiology/immunology[MESH] |*Diabetes Mellitus/blood/epidemiology/immunology[MESH] |*Inflammation/blood/etiology[MESH] |*Thrombophilia/blood/etiology[MESH] |Biomarkers/blood[MESH] |Blood Coagulation[MESH] |Comorbidity[MESH] |Disease Susceptibility[MESH] |Humans[MESH]Markers of coagulation dysfunction and inflammation in diabetic and no(epmc).pdf DeepDyve Pubget Overpricing